PARK7-Mediated Delactylation of SF3B Reprograms RNA Splicing to Attenuate Fibrosis and Promote Antitumor Immunity.

Sun L, Zhou Y, Zhao X, Song L, Chen G, Liu P, Lan P, Liu J

Open source

DOI
10.1158/0008-5472.can-25-5662
Published
2026 Sep 2
Container
Cancer research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/0008-5472.can-25-5662,
  title = {PARK7-Mediated Delactylation of SF3B Reprograms RNA Splicing to Attenuate Fibrosis and Promote Antitumor Immunity.},
  author = {Sun L and Zhou Y and Zhao X and Song L and Chen G and Liu P and Lan P and Liu J},
  year = {2026},
  journal = {Cancer research},
  doi = {10.1158/0008-5472.can-25-5662},
  url = {https://doi.org/10.1158/0008-5472.can-25-5662}
}

RIS

TY  - JOUR
TI  - PARK7-Mediated Delactylation of SF3B Reprograms RNA Splicing to Attenuate Fibrosis and Promote Antitumor Immunity.
AU  - Sun L
AU  - Zhou Y
AU  - Zhao X
AU  - Song L
AU  - Chen G
AU  - Liu P
AU  - Lan P
AU  - Liu J
PY  - 2026
JO  - Cancer research
DO  - 10.1158/0008-5472.can-25-5662
UR  - https://doi.org/10.1158/0008-5472.can-25-5662
ER  - 

APA

L, S., Y, Z., X, Z., L, S., G, C., P, L., P, L., & J, L. (2026). PARK7-Mediated Delactylation of SF3B Reprograms RNA Splicing to Attenuate Fibrosis and Promote Antitumor Immunity.. Cancer research. https://doi.org/10.1158/0008-5472.can-25-5662

Source records